In a study of ovarian reserve in SCD that included females treated with myeloablative Bu/Cy regimens at decreased Cy doses (120–180 mg/kg), all girls/women had very low AMH post-HSCT [65]. The gene discussed is AMH; the disease is Schnyder corneal dystrophy.